Global Vision Leads to Wider Collaboration for Innovative Offerings
Strategic Partnership to Provide Silicon Nitride Spinal Interbody Fusion Devices
Shanghai, December 30, 2015 – BoTEC announced the execution of the strategic partnership with Amedica Corporation (Nasdaq:AMDA) on spine inter-body fusion device that is developed on silicon nitride ceramics as a biomaterial platform. This cooperation will help BoTEC, one of the fastest orthopedic companies in China, to provide innovating solution and optimize the service to spine surgeons and patients.
“We are very pleased to enter into this partnership with Amedica, as they have a unique biomaterial platform that will provide BoTEC Medical interbody solutions with a unique value proposition in a highly competitive market,” said Waldo Shan, Chief Executive Officer of BoTEC Medical. “We look forward to building upon our partnership to meet the ever-increasing surgeon demands while improving patient lives.”
“This strategic alliance further validates the market adoption of our medical-grade silicon nitride technology platform internationally,” said Dr. Sonny Bal, Chairman and Chief Executive Officer. “We are very pleased to partner with BoTEC Medical’s team and look forward to participating in their exciting future as they continue to capture additional market share within and outside one of the fastest growing medical device markets in the world.”
With the promising collaboration between the two fast growing companies, BoTEC is now providing the spinal inter-body fusion device which is made of proprietary micro-composite silicon nitride biomaterial - a breakthrough ceramic containing the world's first inherent nano-surface biotechnology. This unique biomaterial is also hydrophilic to attract both osteoblasts and physiologic proteins to ensure reliable osseointegration, and its surface biochemistry inhibits bacterial biofilm adhesion.
Along with the launch of PINE III Percutaneous Pedical Screw System and PINE IV Posterior Spine System in 2016, BoTEC will offer an optimized posterior TL solution to cover various surgical approaches, MIS or Open, TLIF or PLIF etc.